- Home
- ACHR vs AUTL Comparison
ACHR vs AUTL Comparison
Compare ACHR & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHR
- AUTL
- Stock Information
- Founded
- ACHR 2018
- AUTL 2014
- Country
- ACHR United States
- AUTL United Kingdom
- Employees
- ACHR N/A
- AUTL N/A
- Industry
- ACHR Aerospace
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACHR Industrials
- AUTL Health Care
- Exchange
- ACHR Nasdaq
- AUTL Nasdaq
- Market Cap
- ACHR 1.3B
- AUTL 1.1B
- IPO Year
- ACHR N/A
- AUTL 2018
- Fundamental
- Price
- ACHR $6.03
- AUTL $2.95
- Analyst Decision
- ACHR Buy
- AUTL Strong Buy
- Analyst Count
- ACHR 7
- AUTL 3
- Target Price
- ACHR $8.93
- AUTL $10.20
- AVG Volume (30 Days)
- ACHR 25.1M
- AUTL 2.7M
- Earning Date
- ACHR 11-07-2024
- AUTL 11-12-2024
- Dividend Yield
- ACHR N/A
- AUTL N/A
- EPS Growth
- ACHR N/A
- AUTL N/A
- EPS
- ACHR N/A
- AUTL N/A
- Revenue
- ACHR N/A
- AUTL $10,091,000.00
- Revenue This Year
- ACHR N/A
- AUTL $816.67
- Revenue Next Year
- ACHR $2,048.97
- AUTL $374.47
- P/E Ratio
- ACHR N/A
- AUTL N/A
- Revenue Growth
- ACHR N/A
- AUTL 82.71
- 52 Week Low
- ACHR $2.82
- AUTL $2.69
- 52 Week High
- ACHR $7.02
- AUTL $7.45
- Technical
- Relative Strength Index (RSI)
- ACHR 80.32
- AUTL 32.14
- Support Level
- ACHR $4.15
- AUTL $2.69
- Resistance Level
- ACHR $4.86
- AUTL $3.25
- Average True Range (ATR)
- ACHR 0.46
- AUTL 0.32
- MACD
- ACHR 0.21
- AUTL -0.07
- Stochastic Oscillator
- ACHR 93.83
- AUTL 7.67
About ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.